Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein

Details for Australian Patent Application No. 2004210162 (hide)

International Classifications

Event Publications

15 September 2005 PCT application entered the National Phase

PCT publication WO2004/069166 Priority application(s): WO2004/069166

27 April 2006 Assignment before Grant

The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services; Panacos Pharmaceuticals, Inc. The application has been assigned to The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services; Panacos Pharmaceuticals, Inc.

26 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.